The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?

One of the main players in apoptosis during Alzheimer's disease progression are different members of caspase family of proteases. The most well-known member of this family is caspase-3, in which alterations of its levels have been detected in samples from Alzheimer's disease patients. There are numerous intracellular factors involved in regulation of cellular apoptosis through regulation of caspase-3 activity, the most important of which is the PI3K/AKT signaling pathway. This commentary tries to highlight the probable relations between PI3K/AKT signaling pathway and caspase-3 in Alzheimer's disease.

[1]  M. Khezri,et al.  The Role of Caspases in Alzheimer's Disease: Pathophysiology Implications and Pharmacologic Modulation. , 2022, Journal of Alzheimer's disease : JAD.

[2]  Keyvan Yousefi,et al.  The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments , 2022, Cellular and Molecular Neurobiology.

[3]  Hui-Zhi Long,et al.  PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease , 2021, Frontiers in Pharmacology.

[4]  Saurabh Sharma,et al.  Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease , 2020, Journal of the Neurological Sciences.

[5]  Jie Hao,et al.  Isoforsythiaside Attenuates Alzheimer’s Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway , 2020, International journal of molecular sciences.

[6]  M. Lamkanfi,et al.  Caspases in Cell Death, Inflammation, and Disease. , 2019, Immunity.

[7]  E. Buckley,et al.  Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury , 2019, Neurobiology of Disease.

[8]  P. Hof,et al.  The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease , 2018, Progress in Neurobiology.

[9]  D. Praticò,et al.  Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer’s disease , 2017, Molecular Psychiatry.

[10]  Frederik Barkhof,et al.  Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease , 2016, European Radiology.

[11]  D. Řípová,et al.  Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease. , 2013, Journal of neuropathology and experimental neurology.

[12]  E. Kavanagh,et al.  Caspase signalling controls microglia activation and neurotoxicity , 2011, Nature.

[13]  D. Bennett,et al.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. , 2008, The American journal of pathology.

[14]  A. Jahani-Asl,et al.  Caspase‐3‐mediated cleavage of Akt: Involvement of non‐consensus sites and influence of phosphorylation , 2007, FEBS letters.

[15]  Bengt Winblad,et al.  Akt activity in Alzheimer's disease and other neurodegenerative disorders , 2004, Neuroreport.

[16]  K. Blomgren,et al.  Involvement of Caspase-3 in Cell Death after Hypoxia–Ischemia Declines during Brain Maturation , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  R. Oppenheim,et al.  Increased Production of Amyloid Precursor Protein Provides a Substrate for Caspase-3 in Dying Motoneurons , 1998, The Journal of Neuroscience.

[18]  M. Lamkanfi,et al.  Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease. , 2019, Cold Spring Harbor perspectives in biology.

[19]  A. Bacci,et al.  Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease , 2011, Nature Neuroscience.

[20]  Mak Adam Daulatzai,et al.  Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.